QHM-2025-8039 Bowburn Pharmacy

The procurement process initiated by the NHS North East and North Cumbria Integrated Care Board concerns the provision of health services, specifically under the title "QHM-2025-8039 Bowburn Pharmacy." The process has reached the award stage, with the contract having started on 1 April 2025 and set to conclude on 31 March 2026. Located in the UKC region, the contract involves services related to stocking palliative drugs, flu antivirals, and MECATS vouchers.

This procurement was conducted via a limited method under the Direct Award Process A, prescribed by the Health Care Services (Provider Selection Regime) regulations 2023, and it is categorically outside the scope of the standard Procurement Act 2023. The contract was awarded to Bowburn Pharmacy, with a nominal value of £0.01, reflecting its nature as an activity-based contract without guaranteed value. This tender offers significant opportunities for businesses, particularly those with expertise in the healthcare sector, by facilitating prescription drug stocking and related services within the specified region.

Large scale enterprises with logistical capacities for pharmaceutical service provision can immensely benefit from such contracts. The award criteria focused on a lack of alternative providers, suggesting a competitive edge for businesses that offer unique or necessary health services. Companies engaged in providing comprehensive pharmaceutical solutions would be well-suited to respond to and potentially grow through such opportunities, leveraging their existing resources and expertise in the healthcare domain.